Eldelumab Uses, Dosage, Side Effects and more
MDX-1100, a fully human antibody that targets IP10 (also known as CXCL10), a chemokine expressed in association with multiple inflammatory disease indications, such as rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis.
| Trade Name | Eldelumab |
| Generic | Eldelumab |
| Eldelumab Other Names | Eldelumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in ulcerative colitis.
How Eldelumab works
MDX-1100 binds selectively to CXCL10 and blocks CXCL10 induced calcium flux and cell migration.
